Cargando…

Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method

Gliclazide is a second-generation hypoglycemic sulfonylurea, which is useful in the treatment of non-insulin-dependent diabetes mellitus. It has low bioavailability because of its limited water solubility and slow dissolution rate. In this study, solid dispersions of gliclazide were prepared by solv...

Descripción completa

Detalles Bibliográficos
Autores principales: Febriyenti, Febriyenti, Rahmi, Suraiya, Halim, Auzal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662042/
https://www.ncbi.nlm.nih.gov/pubmed/31555033
http://dx.doi.org/10.4103/jpbs.JPBS_87_18
_version_ 1783439577946521600
author Febriyenti, Febriyenti
Rahmi, Suraiya
Halim, Auzal
author_facet Febriyenti, Febriyenti
Rahmi, Suraiya
Halim, Auzal
author_sort Febriyenti, Febriyenti
collection PubMed
description Gliclazide is a second-generation hypoglycemic sulfonylurea, which is useful in the treatment of non-insulin-dependent diabetes mellitus. It has low bioavailability because of its limited water solubility and slow dissolution rate. In this study, solid dispersions of gliclazide were prepared by solvent method. Drug and carriers weight ratio were 1:9; 2:8; 3:7; 4:6; and 5:5. The weight ratio of carriers (polyvinyl pyrrolidone K-30 and polyethylene glycol 6000) was 1:1. The properties of solid dispersions were evaluated using scanning electron microscopy (SEM), Fourier-transform infra red (FTIR) spectroscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD), and solubility and dissolution studies. SEM result showed that gliclazide was highly dispersed and was present as amorphous state in the solid dispersions. The FTIR spectroscopy showed no chemical interaction between gliclazide and carriers. DSC studies indicated melting point of gliclazide was decreased. The XRD studies indicated that crystallinity degree of gliclazide was decreased. Rate of dissolution and solubility of solid dispersions was increased than pure gliclazide (F < 0.05).
format Online
Article
Text
id pubmed-6662042
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66620422019-09-25 Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method Febriyenti, Febriyenti Rahmi, Suraiya Halim, Auzal J Pharm Bioallied Sci Original Article Gliclazide is a second-generation hypoglycemic sulfonylurea, which is useful in the treatment of non-insulin-dependent diabetes mellitus. It has low bioavailability because of its limited water solubility and slow dissolution rate. In this study, solid dispersions of gliclazide were prepared by solvent method. Drug and carriers weight ratio were 1:9; 2:8; 3:7; 4:6; and 5:5. The weight ratio of carriers (polyvinyl pyrrolidone K-30 and polyethylene glycol 6000) was 1:1. The properties of solid dispersions were evaluated using scanning electron microscopy (SEM), Fourier-transform infra red (FTIR) spectroscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD), and solubility and dissolution studies. SEM result showed that gliclazide was highly dispersed and was present as amorphous state in the solid dispersions. The FTIR spectroscopy showed no chemical interaction between gliclazide and carriers. DSC studies indicated melting point of gliclazide was decreased. The XRD studies indicated that crystallinity degree of gliclazide was decreased. Rate of dissolution and solubility of solid dispersions was increased than pure gliclazide (F < 0.05). Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6662042/ /pubmed/31555033 http://dx.doi.org/10.4103/jpbs.JPBS_87_18 Text en Copyright: © 2019 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Febriyenti, Febriyenti
Rahmi, Suraiya
Halim, Auzal
Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title_full Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title_fullStr Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title_full_unstemmed Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title_short Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method
title_sort study of gliclazide solid dispersion systems using pvp k-30 and peg 6000 by solvent method
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662042/
https://www.ncbi.nlm.nih.gov/pubmed/31555033
http://dx.doi.org/10.4103/jpbs.JPBS_87_18
work_keys_str_mv AT febriyentifebriyenti studyofgliclazidesoliddispersionsystemsusingpvpk30andpeg6000bysolventmethod
AT rahmisuraiya studyofgliclazidesoliddispersionsystemsusingpvpk30andpeg6000bysolventmethod
AT halimauzal studyofgliclazidesoliddispersionsystemsusingpvpk30andpeg6000bysolventmethod